This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Reasons Why Investors Should Retain American Financial (AFG)
by Zacks Equity Research
American Financial (AFG) is well-poised for growth on business opportunities, acquisitions, favorable estimates and improved guidance.
Reasons Why You Should Retain NMI Holdings (NMIH) Stock
by Zacks Equity Research
NMI Holdings (NMIH) is poised to grow on the expanding U.S. mortgage insurance market, expansion of customer franchise and a well-performing reinsurance market.
3 Top Stocks to Gain as Interest Rates Are Set to Stay Higher
by Tirthankar Chakraborty
Recent strength in the labor market has bolstered rate hike expectations. Invest in financial stocks like State Street (STT), Everest Re Group (RE) & AssetMark Financial (AMK).
Kinsale (KNSL) Up 47.5% in a Year: Can It Maintain the Upside?
by Zacks Equity Research
Kinsale (KNSL) stock rallies on the back of lower levels of operating expenses, higher rates across most lines of business, higher net earned premiums and effective capital deployment.
Best Growth Stocks to Buy for March 2nd
by Zacks Equity Research
UGP, RE and NTTYY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 2, 2023.
The Zacks Analyst Blog Highlights Everest Re, RenaissanceRe, Universal Insurance, Kinsale Capital and Selective Insurance
by Zacks Equity Research
Everest Re, RenaissanceRe, Universal Insurance, Kinsale Capital and Selective Insurance are included in this Analyst Blog.
Surging Earnings Estimates Signal Upside for Everest Re (RE) Stock
by Zacks Equity Research
Everest Re (RE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
5 Momentum Insurance Stocks Defying Headwinds to Buy for March
by Nalak Das
We have narrowed our search to five momentum insurance stocks with double-digit returns year to date. These are RE, RNR, UVE, KNSL and SIGI.
Why Should You Hold Travelers (TRV) Stock in Your Portfolio?
by Zacks Equity Research
Travelers (TRV) continues to benefit from strong net earned premiums, high levels of retention, improved pricing and sufficient liquidity.
RE or CINF: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
RE vs. CINF: Which Stock Is the Better Value Option?
5 Relative Price Strength Plays to Keep for Your Buy List
by Nilanjan Choudhury
OMC, RE, SUN, TXT and POST are five stocks with explosive relative price strength.
Should You Retain Chubb Limited (CB) Stock in Your Portfolio?
by Zacks Equity Research
Chubb Limited (CB) stands to gain from new business and strong renewal retention, expanding underwriting margins, strategic acquisitions and effective capital deployment.
Zacks.com featured highlights include Everest Re Group, Thermo Fisher Scientific and Sony Group
by Zacks Equity Research
Everest Re Group, Thermo Fisher Scientific and Sony Group are part of the Zacks Screen of the Week article.
Reasons Why CNA Financial (CNA) Stock is an Attractive Pick
by Zacks Equity Research
CNA Financial (CNA) is poised to grow on improved current accident year underwriting results and growth in invested asset base and sufficient liquidity.
Is Everest Re Group (RE) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Stocks With Sales Growth to Buy Amid Persistent Inflation
by Swayta Shah
Sales growth is vital for the survival of a business, even during an economic slowdown. Everest Re (RE), Thermo Fisher (TMO) and Sony Group (SONY) are recording top-line growth.
Everest Re (RE) Rises 17% YTD: Will the Bull Run Continue?
by Zacks Equity Research
Segmental strength, a solid capital position and favorable growth estimates poise Everest Re (RE) well for growth.
Reasons Why Arch Capital (ACGL) Stock Is an Attractive Pick
by Zacks Equity Research
Arch Capital (ACGL) stands to gain from solid segmental performances, strategic acquisitions and effective capital deployment.
Reasons Why Selective Insurance (SIGI) is an Attractive Pick
by Zacks Equity Research
Selective Insurance (SIGI) is well-poised to gain from renewal pure price increases, higher direct new business, higher returns on the alternative investments and solid capital position.
Best Growth Stocks to Buy for February 17th
by Zacks Equity Research
RE, GPK and ELF made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 17, 2023.
Are You Looking for a Top Momentum Pick? Why Everest Re (RE) is a Great Choice
by Zacks Equity Research
Does Everest Re (RE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Progressive (PGR) November Earnings Rise on Higher Revenues
by Zacks Equity Research
Progressive's (PGR) November earnings reflect higher premiums improved revenues and net realized gains on securities.
Should You Retain W.R. Berkley (WRB) Stock in Your Portfolio?
by Zacks Equity Research
W.R. Berkley (WRB) is poised to benefit from higher premiums, growing underwriting profits and effective capital deployment.
Reasons Why Cincinnati Financial (CINF) Is an Attractive Pick
by Zacks Equity Research
Cincinnati Financial (CINF) rides on price increases, growth initiatives and higher interest income from fixed-maturity securities.
Here's Why Everest Re (RE) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.